Available online on 15.06.2025 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2025 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Review Article
Khaksi (Sisymbrium irio L.): An updated review of its ethnopharmacology, phytochemistry and pharmacology
Tahoora Tamkanat 1, Fazila Nawab 2, Qamrul Islam Usmani *3, Sadiya Sarwath 4
1 Assistant Professor, Department of Amraz e Atfal, Inamdar Unani Medical College and Hospital, Sedam Road, Kalaburagi, Karnataka, 585105
2 Assistant Professor, Department of Moalajat, Hakeem Abdul Hameed Unani Medical College, Dewas, Madhya Pradesh
3 Assistant Professor, Department of Ilmul Advia (Pharmacology), Inamdar Unani Medical College and Hospital, Sedam Road, Kalaburagi, Karnataka, 585105
4 PG Scholar, Department of Amraz e Jild wa Tazeeniyat, Govt. Unani Medical College, Bengaluru, Karnataka, 560079
|
Article Info: _________________________________________________ Article History: Received 23 March 2025 Reviewed 09 May 2025 Accepted 02 June 2025 Published 15 June 2025 _________________________________________________ Cite this article as: Tamkanat T, Nawab F, Usmani QI, Sarwath S, Khaksi (Sisymbrium irio L.): An updated review of its ethnopharmacology, phytochemistry and pharmacology, Journal of Drug Delivery and Therapeutics. 2025; 15(6):288-296 DOI: http://dx.doi.org/10.22270/jddt.v15i6.7219 _________________________________________________ *Address for Correspondence: Qamrul Islam Usmani, Assistant Professor, Department of Ilmul Advia, Inamdar Unani Medical College and Hospital, Sedam Road, Kalaburagi, Karnataka, 585105 |
Abstract ________________________________________________________________________________________________________________ Sisymbrium irio L. (Khaksi) is an annual or biennial winter herb belonging to the Brassicaceae or Cruciferae family. It has been used as a medicine since antiquity. Today, it is used as a Unani and folk medicine in various regions of the world for its antipyretic, anti-choleric, aphrodisiac, expectorant and appetizer properties. The various parts of the plant possess many phytochemicals such as flavonoids, alkaloids, tannins, saponins, glycosides, beta-sitosterol, oils, etc., which are known to exhibit several pharmacological actions like antioxidative, antimicrobial, antipyretic, anticancer, and hepatoprotective activities. The literature is taken from Unani classical books and online databases like PubMed, Google Scholar, Science Direct, with the keywords khaksi, Sisymbrium irio, phytochemicals, and their pharmacological actions. Keywords: Khaksi; London Rocket; Pyrexia; Sisymbrium irio; Unani medicine
|
Introduction
The Unani system of medicine is one of the oldest traditional medicinal systems that have been used for centuries to prevent and treat a wide range of diseases. Unani system of medicine addresses homeostasis of the body, which depends on the balance of the four humors (akhlat) and temperament (mizaj) which are balanced by six essential factors1. Unani medicine promotes health and treats ailments using a variety of approaches such as regimental therapy, diet therapy, and pharmacotherapy. This system relies mainly on plant-origin drugs, then animal and mineral-origin drugs2,3. Numerous clinical studies have demonstrated the effectiveness of Unani medicines with little or no adverse effects. Many herbal medications have recently undergone standardization, quality assurance, toxicity profiling, and formulations listed in the Unani Pharmacopeia of India have been validated2.
Sisymbrium irio L. (S. irio), belonging to the family Brassicaceae or Cruciferae is an important medicinal plant used in Unani system of medicine. S. irio is often known as Khaksi, Khubah, Khub kalan, London rocket/Rocket mustard, and is found in different parts of the world4. S. irio is native to southern Europe, North Africa and temperate Asia but has been carried by migrants to North America, Australasia and South Africa. The tap-rooted herbaceous plant reproduces entirely by seed5. It grows near roadways, fences, and ditches6,7.
It is used as febrifuge, expectorant, anti-asthmatic, aphrodisiac, cardio-tonic, diuretic, laxative, lubricant, hepato-protective, rubefacient8-10 anti-rheumatic, anti-inflammatory, and also used for dietary purposes; as it is rich in nutrients and protein11. S. irio contains numerous bioactive compounds, including alkaloids, tannins, saponins, flavonoids, glycosides, phenolics, glucosinolates, carbohydrates, fatty acids, amino acids, proteins, and steroids4,12-14. These compounds possess various pharmacological actions such as antipyretic, analgesic, antioxidant15, antibacterial, antifungal, anti-inflammatory, anticancer, hepatoprotective, and bronchoprotective properties16,17. This review explore the potential of Khaksi as mentioned in Unani literature with its phytochemical and pharmacological scientific advancement.
Material and Methods
Khaksi was searched in classical Unani literature for its temperament (mizaj), medicinal properties, and therapeutic applications. Urdu translations of classical textbooks such as Muheet Azam of Hakeem Mohammad Azam Khan, Khazainul Advia of Najmul Ghani, Makhzanul Mufaradat and Bayaz e Kabir of Hakeem Mohammed Kabiruddin, Qarabadeen e Majeedi, National Formulation of Unani Medicine, and others were conferred. Published publications from PubMed, Science Direct, and Google Scholar and Research Gate were used to gather all available information about its phytochemicals and pharmacological research. The proper Unani terminologies were described using Standard Unani Medical Terminology, which was published by the Central Council for Research in Unani Medicine in collaboration with the World Health Organization.
Description of Khaksi in Unani Literature
Table 1: Alternative name in different languages
|
Language/ Region |
Common name |
|
Arabic |
Khubba18-20, Bazarulkhamkham17,19 |
|
Ayurvedic |
Khaaksi9 |
|
Chinese |
Shuisuanjie17 |
|
English |
London Rocket9,18, Rocket mustard17, Hedge-mustard18, Desert rocket17 |
|
Hindi |
Asalio17, Khubkalaan18 |
|
Japenese |
Hosoegarashi17 |
|
Korean |
Git-teol-jang-dae21 |
|
Marathi |
Ranteekhee18 |
|
Persian |
Shibbawa Khakchi18, khubkalas18, Shaftarak17, Tukhm e shehwa19 |
|
Punjabi |
Janglisarson17,18, Maktrusa17,18 |
|
Rajasthani |
Parjan17 |
|
Spanish |
Matacandil17 |
|
Sindh |
Junglisurson17 |
|
Urdu |
Khaksi18, Khubkalan9 |
Morphology (Māhiyat): Khaksi is an annual or biennial, highly variable, stiffly erect, 20 - 60 cm tall, tap-rooted herb. Stems 2-10 mm thick, leaves stalked, pinnatified or partite, lower leaves are broader than the upper leaves, lobes not auricled, tooth distant, terminal large, rarely hastate. The Flowers are yellow, minute, pedicle slender. Pods narrow, erect, 3-5 cm long, subtorulose, glabrous, valves 3 nerved, pedicles curved ascending, and stigma sessile. Seeds are small, pitted, present in series, reddish brown / orangish-brown, mucilaginous with a warty surface; odor pungent like mustard oil and taste like bitter mustard oil7,17,21. The beans of the herb resemble mustard beans but are much smaller and filled with seeds that resemble poppy seeds (Tukhm-i-khashkhash)19,20,23. They are Self-pollinated, and disseminated through seeds7.
Parts used (Hasas-i-Musta'mla): Leaves and seeds24
Temperament (Mizāj): Unani system of medicine places a strong emphasis on drug temperament as a fundamental notion for understanding drug activity. The relationship between a person's temperament and a drug's temperament provides a foundation for the effective use of drugs, forecasting its effects, and determining potency. Unani physicians categorize medications into four categories (hot, cold, wet, and dry) based on their impact on a moderate human body25. The temperament of Khaksi is hot and wet in the second degree18,20,23; hot in second degree and wet in first degree26.
Action and uses (Af’āl wa Mawāq-e-istemāl)
Table 2: Action and uses of Khaksi in Unani medicine
|
Action (Af’āl) |
Uses (Mawāq-e-istemāl) |
|
Dāfi-i-hummā (Antipyretic)9,18-20,27 and Mu’arriq (Diaphoretic)18 |
Fever, measles, smallpox, Diq-ul-atfāl (T.B. in children) |
|
Munaffith-i-balgham (Expectorant)18,23,27,28 |
Chronic cough, asthma, pulmonary infections, Diq-ul-atfāl |
|
Munaffith akhlat-i-sadr18 |
Infections of throat and chest, hoarseness of voice |
|
Mushtahi (Appetizer)19 and Muqawwi-i-mi’da (Stomachic)19 |
Appetizer, helps in digestion, stomach tonic, gastric ulcer |
|
Musakkin-i-alam (Analgesic) and Muḥallil-i-awrām (anti-inflammatory)17 |
Rheumatism, arthritis, inflammation, clean wounds |
|
Mufattiḥ sudda (Deobstruent)19 |
Vascular and airway disorder, atherosclerosis, asthma |
|
Muqaww-i-bāh (aphrodisiac)19,20,26,29,30 |
Powder is used in ḍu’f al-bāh (sexual debility), sur’a al-inzāl (premature ejaculation), jarayān (semenorrhoea) and kathra al-ihtilām (nocturnal emission) |
|
Musammin-i-badan,21,30,31 |
Increases the weight when taken with milk |
|
Mudirr-i-bawl (Diuretic)17,30 |
Decoction is used in the retention of urine, dysuria, and urinary tract infection |
|
Naf-i-haiḍa18-20,23,30 |
Effective in cholera and decreases vomiting when taken as decoction with rose water (arq-i-gulab) |
|
Amrāḍ-i-jild (Skin disorders)17 |
acne, boil/furuncle, urticaria |
|
Amraḍ-i-niswan30 |
Used in amenorrhea and dysmenorrhea. Also used as vaginal pessary in some vaginal and uterine infections |
Dose (Miqdār-i-khorāk): The dose of khaksi is 5-7g or 9 g.18,23,30
Adverse effects (Muzir): As per Unani concept hot temperament (garam mizaj) individuals may show headache when used higher to therapeutic dose26,30.
Correctives (Musleḥ): Katira (Sterculia urens)26,30, Gulab (Rosa damascena Mill.)30
Substitute (Badal): Toodri (Cheiranthus cheiri L.)26,30
Compound formulation:
Table 3: Famous Unani compound formulations of Khaksi, uses and doses
|
Name of compound formulation & their forms |
Therapeutic use |
Dose |
|
Sharbat-i-Khaksi (syrup form)18,23,31,32 |
Judri (smallpox), Hasba (measles) Moti jhara (enteric fever), Naubati hummiyat (intermittent fever) |
25 ml |
|
Dawa-e-Diqq-ul-Atfal (powder form)33,34 |
Humma-e- Diqq-ul-Atfal (Juvenile tuberculosis) |
1 g |
Description of Khaksi in the Scientific Literature
Taxonomical classification: Domain: Eukaryota; Kingdom: Plantae; Phylum: Spermatophyta; Subphylum: Angiospermae; Class: Dicotyledonae; Order: Capparidales; Family: Brassicaceae; Genus: Sisymbrium; Species: irio17
Phytochemistry
Various important secondary metabolites viz. alkaloids, flavonoids, glycosides, phenols, terpenes, tannins, steroids, and others like amino acid, proteins, carbohydrates and minerals are found in the seed of khaksi35,36,37. Abdul Haleem et. al. (2017) has performed the standardization and safety profile of seeds of khaksi. Important bioactive compounds from different parts of S. irio have mentioned in the table 4.
Table 4: Important bioactive compounds identified in various part of Khaksi
|
Chemical constituents |
Parts used/ Dosage form |
Ref |
|
Flavonoid, isorhamnetin |
Seeds |
9 |
|
Fatty acid: linolenic acid, linoleic acid, oleic acids, erucic acid, cis-11-Eicosanoic acid, palmitic acid, stearic acids and minerals viz. calcium, iron, sodium, zinc, potassium, strontium, titanium, chromium, manganese, copper, boron, aluminium, silicon, barium, phosphorus, |
Seeds |
9,38,39
|
|
Phenol; Oleic acid, Docosanoic acid, Tetradecanoic acid, Pentadecanoic acid, Hexadecanoic acid, 9-Octadecenoic acid (Z)-, Benzene-1,2-dicarboxylic acid; 4-(Dimethoxymethyl)-1,2-dimethylbenzene; 2,4-bis(1,1-dimethylethyl); 2-propenyl ester, 2-hydroxy-1,3-propanediyl ester, palmitoyl chloride, 2-hydroxy-1-(hydroxymethyl)ethyl ester, methyl ester, docosyl ester, 2,3-dihydroxypropyl ester; 7-(Bromomethyl)-7-pentadecene, Cholesta-3,5-diene; 2-Cyclohexen-1-one, 3,5,5-trimethyl-2-(2-propenyl); Palmitoyl chloride |
Seeds / Ethanolic |
40
|
|
Vitamin C, beta-carotene and minerals |
Leaves |
9 |
|
Apigetrin (apigenin-7-O-glucoside), apigenin, isoquercetin, isorhoifolin, trans-p-coumaric acid, trans-ferulic acid, gallocatechin, luteolin, nicotiflorin, naringenin, glucobrassicin, glucoputranjivin |
Leaves / Ethanolic |
41
|
|
Cyclopentanol, Decane, Dodecane, Tetradecane, Hexadecane, Eicosane, Hexadecanoic acid, methyl ester, 1,2-Benzenedicarboxylic acid, Orotic acid, Hexadecanoic acid, 1,2-Benzenedicarboxylic acid, 10-Octadecenoic acid, methyl ester, Phytol, Colfosceril palmitate, Campesterol, β-sitosterol, tert-butyldimethylsilyl ester, Di-n-octyl phthalate, bis(2-ethylhexyl) ester, diundecyl ester, |
Leaves/ Methanolic |
42
|
|
Phenols: chlorogenic acid, ferulic acid, kaempferol, coumaric acid, protocatechuic acid, vanillic acid |
Leaves / Methanolic |
43 |
|
Beta-sitosterol, quercetin, isorhamnetin and 3 beta-D-glucoside8 |
Aerial |
9 |
|
Flavonoids: apigenin, kaempferol-3-O -xyloside-7-galactoside, kaempferol, apigenin-7-galactoside, apigenin-7-O-gluco(6”,1’’’) rhamnoside-5-methoxide, apigenin-7-O-β-D-glucoside, apigenin-7-O-gluco(6”,1’’’) rhamnoside, luteolin-7-O-glucoside, apigenin-7-O-gluco(6”,1’’’) rhamnoside, apigenin-7-di-glucoside, apigenin-7-O-(6” acetyl) glucoside, apigenin-7-O-β-D- galactoside |
Aerial |
12,44
|
|
Ascorbic acid, vanillin, benzoic acid, catechol, salicylic acid, quercetin |
Ethanolic |
45 |
|
Sitosteryl-6ʹ-O-undecanoate-β-D-glucoside, (Z)-8, 11, 12-trihydroxyoctadec-9-enoic acid, 1,2-dipalmitoyl- 3-O-α-6ʹʹʹsulfoquinovosyl glycerol, naringenin-4ʹ-O- glucopyranoside, -adenosine, crotanoylcosmosiin, tetracosanoic acid, apigenin, β-sitosterol, ursolic acid, -sitosterol-D-glucoside, indole-3-carboxaldehyde and indole-3-carboxylic acid |
Aerial |
13
|
|
Quercetin, dioctyladipate, Isorhamanetin, N-(n-propyl) acetamide, Isopropyl isothiocyanate, Isobutyl isothiocyanate, n-butyl isothiocyanate, Indole-3carboxaldehyde, Indole-3-carboxylic acid, 3-Methyl indole, Apigenin, 2E-Hexenal, Dimethyl sulphone, beta-Terpinyl acetate, p-Anisaldehyde, Indole, p-Vinylguaiacol, 1,1,6-Trimethyl-1,2,3,4tetrahydronaphthalene, o-Benzyl-L-serine, Isovanillin, Methoxyeugenol, 2-(2-Methylpropylidene)-1H-indene-1,3(2H)-Dione |
Aerial |
13,14,46
|
|
Nicotine (alkaloid) |
Aerial / maceration in HCl |
47
|
|
Fatty acids - (7Z,10Z,13Z)-hexadecatrienoic acid (roughanic acid), 9Z,12Z,15Z)-octadecatrienoic acid (α-linolenic acid), 8,11,12-trihydroxy-9Z-octadecanoic acid Indole alkaloids- 1H-indole-3-acetonitrile, 1-methoxyindole 3-acetonitrile, 1-methoxy-1H-indole-3-carboxamide, α-amino-3-indole propenamide (L-tryptophanamide) |
Aerial / Ethanolic |
48 |
Pharmacological actions
|
Pharmacological activities |
Parts used/ Dosage forms |
Model used |
Outcome |
Ref |
|
Antibacterial and Antifungal |
Roots / Methanolic |
In-vitro |
Effective against Gram positive bacteria (Bacillus subtilis, B. pumilus and S. aureus), and Gram-negative bacteria (P. vulgaris, P. aeruginosa and E. coli) and yeast (Candida albicans) |
49 |
|
Leaves / n-hexane |
Agar well diffusion and Tube dilution method |
Inhibit the growth of K. pneumonia and S. epidermidus |
50 |
|
|
Seeds / n-hexane |
-do- |
Inhibition against P. aeroginosa and S. epidermidus |
||
|
Leaves / Ethyl acetate |
-do- |
Inhibit K. pneumonia, E. coli and P. aeruginosa |
||
|
Seeds/ Ethyl acetate |
-do- |
Inhibit K. pneumonia, S. epidermidus and S. aureus |
||
|
Leaves and roots/ Methanolic, n- butanol and chloroform |
--- |
Potent anti-fungal constituents for the management of Macrophomina phaseolina, a soil borne plant pathogen |
6 |
|
|
Leaves / Silver nanoparticles |
strain ATCC E. coli-25922 by agar well diffusion method |
showed a dose-dependent response and effectively inhibited the intrinsic MDR pathogens A. baumanii and P. aeruginosa45 |
51 |
|
|
Seeds / Aqueous (Si-AgNPs) |
--- |
Si-AgNPs at 80μg/ml demonstrated a marked reduction in mycelial growth and spore germination of potent fungal phytopathogens that includes Alternaria alternata, A. brassicae, Fusarium solani, F. oxysporum, and Trichoderma harzianum |
7 |
|
|
Seeds/ Maceration in different solvents like methanol, chloroform, acetone, etc. |
Agar-well diffusion method |
The ethanolic extract was found to be active against E. coli, S. aureus, P. aeruginosa strains as compared to other solvent extracts |
40 |
|
|
Aerial/ Successive extraction |
Agar well diffusion and Disc diffusion methods |
Growth of E. aerogenes, A. baumannii, K. pneumoniae was inhibited |
44 |
|
|
Aerial / ethyl acetate fraction |
Mice |
The bacteriuria decreased and disappeared from urine after 6 days against E. faecalis, Citrobacter freundii and A. baumannii. |
44 |
|
|
Aerial/ Crude Aqueous |
Disc diffusion methods |
Shows potent inhibition against six MDRB isolates viz. P. aeruginosa, A. baumannii, E. cloacae, E. faecium, K. pneumoniae, S. aureus and Candida albicans. |
52 |
|
|
Antipyretic |
Seeds / Ethanol |
Albino Rats |
Antipyretic effect starts within 1 hour and last for 5 hours. (peak at 3 hour) |
15 |
|
Decoction and aqueous |
Wistar albino rat |
Shows mild activity after 3rd and 4th hr of drug administration |
53 |
|
|
Aqueous |
Yeast-induced pyrexia model in rats |
A highly significant effect was observed in animals in pre-treated and post- treated aqueous group |
54 |
|
|
Anti-inflammatory |
Decoction |
Rat |
Hind paw oedema reduced by 27.7% at higher dose |
53 |
|
Aqueous |
Rat |
Hind paw oedema reduced by 23.3% at higher dose |
||
|
Seeds / Ethanol |
Cotton Pellet induced Granuloma Pouch in Wistar rat |
Showed significant (p‹0.001) anti-inflammatory effects at a dose of 100-200mg/kg |
16 |
|
|
Analgesic |
Seeds / Ethanol |
Albino rat |
Showed marked analgesic effect |
15 |
|
Seeds/ Decoction and aqueous |
Rat |
It shows mild to moderate analgesic effect |
53 |
|
|
Antioxidant |
Aerial parts / successive extraction |
DPPH free radical scavenging assay |
The highest antioxidant property was found in total alcohol, butanol, ethyl acetate |
12 |
|
Leaves, stem/ ethyl acetate, butanol, chloroform |
DPPH free radical scavenging assay |
showed marked scavenging activities ranging from IC50: 74.2 to 89.6 μg/ml, |
35 |
|
|
Anti-ulcerogenic |
Aerial / Ethanol |
Acetic acid-induced colitis on male Wistar rat |
The result shows potent dose-dependent anti-ulcerative colitis activity in prophylactic and curative models at doses (125mg, 250 and 500 mg/kg) |
55 |
|
Aerial / Ethanol |
Ethanol induced gastric ulcer model in Wister rat and Swiss albino mice |
At the high dose (500 mg/kg) S. irio was as effective as lansoprazole (30 mg/kg) in reducing all parameters of peptic ulcer by decreasing serum gastrin level |
56 |
|
|
Cytotoxic |
Aerial / n-hexane, n-butanol, ethyl acetate fractions |
Human cancer cell lines HCT-116, HepG2, and MCF-7 / Crystal Violet Staining method |
The n-hexane extract was found to have potent cytotoxic effects |
57 |
|
Seeds / Aqueous (Si-AgNPs) |
The MTT assay on HeLa (human cervical cancer cell line) |
At higher concentration the number of viable cells decreased, with an IC50 value of 22.06 ± 0.86 μg/ml, which demonstrated good activity against cancer cells |
7 |
|
|
Whole plant (ZnO NPs) / Methanol, hexane, ethyl acetate, chloroform |
Normal-Baby hamster kidney cell line (BHK) Malignant-hepatocellular Ca cell line (HepG2) |
The methanol fraction showed the highest activity of 90%, followed by hexane -86.72%, ethyl acetate - 85%, and chloroform 84% against BHK and HepG2 cell lines |
37 |
|
|
Aerial / Aqueous |
VERO cell line from kidney of an African green monkey |
Dose dependent effect was observed |
52 |
|
|
Antiproliferative |
Leaves / Hydroalcoholic |
HT-29 Cancer Cells |
after 48 and 72 h of treatment, the MTT assay shows concentration- and time-dependent inhibitory effects on HT-29 cell |
41 |
|
Bronchoprotective |
Seed / Ethanol |
Aerosol-Induced Bronchospasm in Guinea-pig |
The result shows protection from the bronchospasm stimulated by histamine aerosol at the dose of 100-200mg/kg |
16 |
|
Bronchodilator |
Seed / Aqueous-methanolic |
Isolated rabbit trachea strip |
exhibited nonspecific relaxant effect on carbachol (1μM)-and high concentration K⁺ (80 mM)-induced tracheal contractions suggesting the coexistence of Ca²⁺ antagonistic and/or antimuscarinic properties |
58 |
|
Hepatoprotective |
Aerial / methanol and ethyl acetate |
CCL4 induced liver damage in Albino rat |
The extracts show significant hepatoprotective activity due to decrease in concentration of bilirubin, ALP, SGPT, and SGOT |
59 |
|
Hypoglycaemic |
Leaves / Lipophilic and hydrophilic fraction |
α-amylase inhibition assay using α-amylase porcine pancreatic enzyme |
The lipophilic fraction shows higher porcine pancreatic α-amylase inhibitory effect in comparison with Acarbose, while the hydrophilic fraction of this plant has less α-amylase inhibitory effect |
60 |
|
Vasodilator/ Antihypertension |
Seed / 70% aqueous-methanolic |
Isolated rabbit aorta |
relaxed the phenylephrine (1 μM) and high concentration K⁺ (80 mM)-induced aortic contraction (0.01-3 mg/mL), suggesting blockade of Ca²⁺ channel |
58 |
|
Scientific studies of Khaksi as ingredient in compound formulation |
||||
|
Antipyretic |
Polyherbal formulation/ Khaksi Seeds as ingredient |
Yeast-induced pyrexia model in rats at dose of 150 and 300 mg/kg bw |
high dose (300 mg/kg bw) showed a substantial (p<0.001) decrease in rectal temperature 60 minutes after treatment |
61 |
|
Analgesic |
Polyherbal formulation/ Khaksi Seeds as ingredient |
acetic acid-induced writhing test in mice |
A reduction of writhes by 36.71% and 68.71% respectively at doses of 300 and 600 mg/kg bw |
61 |
|
Antibacterial |
Sharbat Khaksi |
Salmonella typhi isolates |
77% isolates were sensitive to sharbat khaksi and showed bacteriostatic action |
62 |
Acute toxicity study
The seeds of Khaksi were tested for Acute toxicity in Wistar rat and Swiss mice at different doses level following OECD guideline-423. The result showed that seeds have safe upto the doses of 1000mg/kg, but at dose of 2000 mg/kg few percentages of mortality was recorded in both strains63.
Conclusion
After reviewing the literature and scientific studies, it can be concluded that Khaksi is a drug that has been used in Unani system of medicine for the treatment of pyrexia in epidemic conditions since a long time, that is supported by advanced phytochemicals and pharmacological research. The flavonoids found in Khaksi, particularly apigetrin has drawn attention due to its potential to target cancer cell of multiple organs selectively, it may be a good candidate for further exploration in various ailments.
Acknowledgment: The authors are highly obliged to Principal and Librarian, Inamdar Unani Medical College and Hospital, Kalaburagi to provide facilities in the library to review the literature regarding the topic and providing better internet facility to access online materials. Furthermore, authors are thankful to the authors, editors, and publishers of all those books and journals from where the literature of this article has been reviewed.
Declaration of competing interest: There is no conflict of interest.
Authors' contributions: All authors equally contributed in preparation of this manuscript.
Funding source: There is no funding source.
Ethical Approval: Not applicable
References
1. Ansari S, Khan QA, Anjum R, Siddiqui A, Sultana K. Fundamentals of Unani system of medicine-a review. EJBPS. 2017;4(9):219-23.
2. Parveen A, Parveen R, Akhatar A, Parveen B, Siddiqui KM, Iqbal M. Concepts and quality considerations in Unani system of medicine. Journal of AOAC International. 2020;103(3):609-33. https://doi.org/10.5740/jaoacint.19-0284 PMid:31547901
3. Ahmad B, Akhtar J. Unani system of medicine. Pharmacogn Rev. 2007;1(2):210-14.
4. Hailu T, Gupta RK, Rani A. Sisymbrium irio L.: a herb used in the Unani system of medicine for broad spectrum therapeutical applications. Indian J. Tradit. Knowl. 2019;140-43.
5. Mohammad A, Verma S, Mahmooduzzafar, Iqbal M. Morpho-Anatomical Variations in Sisymbrium irio L. Plants Raised from Seeds Treated with γ Radiation. ACS omega. 2024 Sep 25;9(40):41446-55. https://doi.org/10.1021/acsomega.4c04781 PMid:39398157 PMCid:PMC11465646
6. Javaid A, Afzal L, Shoaib A. Antifungal potential of a brassicaceous weed Sisymbrium irio against Macrophominaphaseolina. Planta Daninha. 2017;35: e017164280. https://doi.org/10.1590/s0100-83582017350100057
7. Rizwana H, Bokahri NA, Alfarhan A, Aldehaish HA, Alsaggabi NS. Biosynthesis and characterization of silver nanoparticles prepared using seeds of Sisymbrium irio and evaluation of their antifungal and cytotoxic activities. Green Processing and synthesis. 2022;11(1):478-91. https://doi.org/10.1515/gps-2022-0048
8. Kirtikar KR. and Basu BD. Indian Medicinal Plants, 2nd edition, vol.1. Dehradun: International Book Distributors;153-154.
9. Khare CP. Indian Medicinal Plants. Noida: Saurabh Printers Pvt Ltd.; 2008; 607. https://doi.org/10.1007/978-0-387-70638-2 PMCid:PMC2705749
10. Hussain M, Waqas HM, Raza SM, Farooq U, Ahmed MM, Majeed A. Anti-cholinergic and Ca2+-antagonist mechanisms explain the pharmacological basis for folkloric use of Sisymbrium irio Linn. in gastrointestinal, airways and vascular system ailments. J. Ethnopharmacol. 2016; 193:474-80. https://doi.org/10.1016/j.jep.2016.09.028 PMid:27693774
11. Guil JL, Rodríguez-Garcí I, Torija E. Nutritional and toxic factors in selected wild edible plants. Plant Foods Hum. Nutr. 1997; 51:99-107. https://doi.org/10.1023/A:1007988815888 PMid:9527345
12. Al-Jaber NA. Phytochemical and biological studies of Sisymbrium irio L. Growing in Saudi Arabia. J. Saudi Chem. Soc. 2011;15(4):345-50. https://doi.org/10.1016/j.jscs.2011.04.010
13. Al-Qudah MA, Abu Zarga MH. Chemical composition of essential oils from aerial parts of Sisymbrium irio from Jordan. J. Chem. 2010;7(1):6-10. https://doi.org/10.1155/2010/973086
14. Al-Qudah MA, Abu Zarga MH. Chemical constituents of Sisymbrium irio L. from Jordan. Nat Prod Res. 2010;24(5):448-56. https://doi.org/10.1080/14786410903388025 https://doi.org/10.1080/14786410903388025 PMid:20306367
15. Vohora SB, Naqvi SA, Kumar I. Antipyretic, analgesic and antimicrobial studies on Sisymbrium irio. Planta Medica. 1980;38(03):255-9. https://doi.org/10.1055/s-2008-1074870 PMid:6966062
16. Singh RK. Acute-Toxicity, Anti-Inflammatory and Bronchial Smooth Muscles Investigation of Sisymbrium irio Linn (Seeds) in Experimental Animal Models. Int. J. Res. Stud. Biosci. 2015:48-53.
17. Tiwari M, Bhargava P. Current updates on Sisymbrium irio linn: A traditional medicinal plant. Plant Arch. 2021;21(1):411-419. https://doi.org/10.51470/PLANTARCHIVES.2021.v21.no1.058
18. Anonymous. The Unani Pharmacopoeia of India, part 1, vol 5. New Delhi: Dept of AYUSH;2006.
19. Khan M. Muheet e Azam (urdu translation) Vol. II. New Delhi: CCRUM Publication; 2018; 411-12.
20. Ghani N. Khazain ul Advia (Musawwir edition) Vol. I-IV. 3rd ed. New Delhi: Idara kitab us-Shifa; 2011; 680.
21. Kim HW, Choi TY, Son DC, Jo H, Lee SR. Sisymbrium irio L. (Brassicaceae): a new alien plant in Korea. Bio Invasions Record. 2021;10(2):453-466. https://doi.org/10.3391/bir.2021.10.2.23
22. Vardhana R. Direct uses of medicinal plants and their identification, 1st edition. New Delhi: Sarup and sons; 2008; 319.
23. Kabiruddin M. Makhzanul Mufaradat Al Maruf khawasuladvia. New Delhi: Faisal Publication; 2000;263.
24. Ishtiaq M, Hanif W, Khan MA, Ashraf M, Butt AM. An ethnomedicinal survey and documentation of important medicinal folklore food phytonims of flora of Samahni valley, (Azad Kashmir) Pakistan. Pak. J. Biol. Sci. 2007;10(13):2241-56. https://doi.org/10.3923/pjbs.2007.2241.2256 PMid:19070189
25. Usmani QI, Ahmad A, Jamaldeen FN. Laurus nobilis L., (Habb-ul-Ghar), a review on phytochemistry, pharmacology and ethnomedicinal uses. J. Drug Deliv Ther. 2021;11(5):136-44. https://doi.org/10.22270/jddt.v11i5.5021
26. Nabi GM. Makhzan ul Mufredat wa Murakkabat maroof ba Khwasul Advia. 2nd ed. New Delhi: CCRUM; 2007; 124.
27. Nadkarni KM. Indian Materia Medica, Vol I. 3rd ed. Mumbai: Popular Prakashan Limited; 2009; 1142.
28. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: Council of Scientific and Industrial Research; 1956; 228.
29. Hakeem M A. Bustan ulMufaradat. New Delhi: Idara Kitab Shifa; 2002; 256.
30. Usmani I. Tanqeehul Mufaradat. New Delhi: Ejaz Publication House; 2008;117-118.
31. Anonymous. National Formulation of Unani Medicine, vol.1, part 5th. New Delhi: CCRUM; 2006;160.
32. Anonymous. Qarabadeen e Majeedi. New Delhi: All India Unani Tibbi Conference; 1986;209.
33. Anonymous. National Formulation of Unani Medicine, vol.1, part 2. New Delhi: CCRUM; 2007;124.
34. Kabiruddin M. Bayaz e Kabir, Vol-2. New Delhi: Shoukat Book Depot; 78.
35. Khalil HE, Aljeshi YM, Saleh FA. Phytochemical analysis and in vitro antioxidant properties of Sisymbrium irio L. growing in Saudi Arabia: A comparative study. Res. J. Pharm. Biol. Chem. Sci. 2017; 8:2533-40.
36. Haleem A, Rauf A, Latif A, Siddiqui N, Rehman S. Standardization and safety profile of seeds of Sisymbrium irio Linn (Khaksi). J Med Erudite. 2016;4(1):7-19.
37. Maher S, Nisar S, Aslam SM, Saleem F, Behlil F, Imran M, et.al. Synthesis and characterization of ZnO nanoparticles derived from biomass (Sisymbrium irio) and assessment of potential anticancer activity. ACS omega. 2023;8(18):15920-31. https://doi.org/10.1021/acsomega.2c07621 PMid:37179630 PMCid:PMC10173346
38. Kazemeini SM, Tarzi BG, Bakhoda H, Larijani K, Damanafshan P. Evaluation of the minerals content and fatty acids profiles in Descurainia Sophia and Sisymbrium irio. Bulg. Chem. Commun. 2015; 47:112-8.
39. Hailu T, Gupta RK, Rani A. Phytochemicals and antioxidant activity of Sisymbrium irio L. seeds. Indian J. Tradit. Knowl. 2021; 20(1):26-32 https://doi.org/10.56042/ijtk.v20i1.30046
40. Tiwari M, Bhargava P. In vitro and in silico evaluation of antibacterial activities of different solvent extracts made from Sisymbrium irio L. seeds. J. Appl. Nat. Sci. 2024;16(3):1344-53. https://doi.org/10.31018/jans.v16i3.5802
41. Chileh-Chelh T, da Cunha-Chiamolera TP, Urrestarazu M, Ezzaitouni M, López-Ruiz R, Nájera C, Rincón-Cervera MÁ, et al. London Rocket (Sisymbrium irio L.) as healthy green: bioactive compounds and bioactivity of plants grown in wild and controlled environments. Molecules. 2024;30(1):31. https://doi.org/10.3390/molecules30010031 PMid:39795089 PMCid:PMC11721195
42. Akhtar R, Javaid A, Qureshi MZ. Bioactive constituents of shoot extracts of Sisymbrium irio L. against Fusarium oxysporum F. sp. cepae. Planta Daninha. 2020;38: e020200961. https://doi.org/10.1590/s0100-83582020380100008
43. Al-Taie GR, Al-Mashea RA, Saddon N, Al-Anbari AK. A comparative study of the phenolic compounds of some Brassicaceae taxa by High-performance liquid chromatography (HPLC) technique. Tikrit Journal of Pure Science. 2018;23(2):45-8. https://doi.org/10.25130/tjps.v23i2.650
44. Mohamed NH, Hassan GO, Mahdi HM, Soliman GA, Abdel Shakour EH. Biological activity of sisymbrium irio and petranthus dichotomus and their isolated compounds against microbes causing urinary tract infections. Egypt. J. Desert Res. 2024;74(2):495-514. https://doi.org/10.21608/ejdr.2024.331762.1190
45. Al-Mandeel FA. Study on the active compounds of Sisymbrium irio L. grown in agricultural fields west of mosul city. Biomed. Res. 2022;33(5):128-36.
46. Tiwari M, Gupta S, Bhargava P. Virtual screening and molecular dynamics simulation studies to predict the binding of Sisymbrium irio L. derived phytochemicals against Staphylococcus aureus dihydrofolate reductase (DHFR). J. Appl. Nat. Sci. 2022;14(4):1297-1307. https://doi.org/10.31018/jans.v14i4.3641
47. Alsaffar DF, Abbas IS, Dawood AH. Investigation of the Main Alkaloid of London Rocket (Sisymbrium irio L) as a Wild Medicinal Plant Grown in Iraq. Int. J. Pharm. Sci. Rev. Res. 2016;39(1):279-81.
48. Al-Massarani SM, Aldurayhim LS, Alotaibi IA, Abdelmageed MW, Rehman MT, Basudan OA, et. al. Biomarker quantification, spectroscopic, and molecular docking studies of the active compounds isolated from the edible plant Sisymbrium irio L. Pharmaceuticals. 2023;16(4):498. https://doi.org/10.3390/ph16040498 PMid:37111255 PMCid:PMC10146147
49. Khan FZ, Asif Saeed AS. Antimicrobial potentials of the constituents of Sisymbrium irio L. Hamdard Medicus. 2000;1(43):22-28.
50. Bibi S, Mashwani ZU, Rahman K, Raja NI. Biological screening of polarity-based extracts of leaves and seeds of Sisymbrium irio L. Pak. J. Bot. 2015; 47:301-5.
51. Mickymaray S. One-step synthesis of silver nanoparticles using Saudi Arabian desert seasonal plant Sisymbrium irio and antibacterial activity against multidrug-resistant bacterial strains. Biomolecules. 2019;9(11):662. https://doi.org/10.3390/biom9110662 PMid:31661912 PMCid:PMC6920946
52. El-Sherbiny GM, Moghannem SA, Sharaf MH. Antimicrobial activities and cytotoxicity of Sisymbrium irio L. extract against multi-drug-resistant bacteria (MDRB) and Candida albicans. Int J Curr Microbiol App Sci. 2017; 6:1-3. https://doi.org/10.20546/ijcmas.2017.604.001
53. Kumar YRS, Jaya N, Sasikala CK. Analgesic, Antipyretic and anti-inflammatory effects of Sisymbrium irio L. seeds, J.D.R.A.S. Vol. XXXIII-XXXIV, No.1-4; 2012-13: 31-42.
54. Malik FA. Experimental study for anti-pyretic activity of Khaksi (Sisymbrium irio L.). Doctoral dissertation, Rajiv Gandhi University of Health Sciences (India).
55. El-Meligy RM, Awaad AS, Soliman GA, Bacha AB, Alafeefy AM, Kenawy SA. Prophylactic and curative anti-ulcerative colitis activity and the possible mechanisms of action of some desert plants. J. Enzyme Inhib. Med. Chem. 2015;30(2):250-8. https://doi.org/10.3109/14756366.2014.915394 PMid:24811429
56. El-Meligy RM, Awaad AS, Soliman GA, Kenawy SA, Alqasoumi SI. Prophylactic and curative anti-ulcerogenic activity and the possible mechanisms of action of some desert plants. Saudi Pharm. J. 2017;25(3):387-96. https://doi.org/10.1016/j.jsps.2016.10.008 PMid:28344494 PMCid:PMC5357099
57. Al-Massarani SM, El Gamal AA, Alam P, Al-Sheddi ES, Al-Oqail MM, Farshori NN. Isolation, biological evaluation and validated HPTLC-quantification of the marker constituent of the edible Saudi plant Sisymbrium irio L. Saudi Pharm. J. 2017;25(5):750-9. https://doi.org/10.1016/j.jsps.2016.10.012 PMid:28725148 PMCid:PMC5506741
58. Ahmed MM, Hussain M, Farooq U, Raza SM, Andleeb S, Majeed A et.al. The pharmacological basis for vasodilator effect of Sisymbrium irio Linn. validates it's folkloric use in hypertension. Hypertension. 2019;74(Suppl-1):1123. https://doi.org/10.1161/hyp.74.suppl_1.P1123
59. Alsaffar DF, Ali KH, Alsaffar SF, Dawood AH. Hepatoprotective effects of London rocket (Sisymbrium irio L.) extract against CCL4 induced hepatotoxicity in albino rats. Int J Pharm Sci Rev Res. 2017;46(1):8-12.
60. Hawash M, Jaradat N, Elaraj J, Hamdan A, Lebdeh SA, Halawa T. Evaluation of the hypoglycemic effect of seven wild folkloric edible plants from Palestine: (Antidiabetic effect of seven plants from Palestine). J Altern Complement Med. 2020;17(1):20190032. https://doi.org/10.1515/jcim-2019-0032 PMid:31323003
61. Khanam S, Zakir M, Husain GM, Husain MK, Kazmi MH, Urooj M. Antipyretic and analgesic activity of polyherbal Unani formulation in experimental animals. Res J Pharm Technol. 2024;17(7):3189-96. https://doi.org/10.52711/0974-360X.2024.00499
62. Ganguly R, Mishra P, Sharma A. Sensitivity of Salmonella typhi isolated from patients in Roorkee to antibiotics and two Unani drugs. Indian J Microbiol. 2001;41(3):211-3.
63. Singh RK. Acute-Toxicity, Anti-inflammatory and bronchial smooth muscles investigation of Sisymbrium irio Linn (seeds) in experimental animal models. Int. J. Res. Stud. Biosci. 2015:48-53.